SWKS
33
-10
KO
44
2
IFF
53
2
INTC
49
16
KEY
46
-2
DVN
29
4
CMI
67
4
HRL
30
-3
EMC
53
-3
VLO
42
2
DRI
56
2
IP
70
-3
UNH
63
-2
WHR
70
4
SJM
16
-3
MAT
38
-3
MMM
42
5
QRVO
4
-2
LNC
45
-4
IVZ
49
-3
SWKS
33
-10
KO
44
2
IFF
53
2
INTC
49
16
KEY
46
-2
DVN
29
4
CMI
67
4
HRL
30
-3
EMC
53
-3
VLO
42
2
DRI
56
2
IP
70
-3
UNH
63
-2
WHR
70
4
SJM
16
-3
MAT
38
-3
MMM
42
5
QRVO
4
-2
LNC
45
-4
IVZ
49
-3
Financhill
Back

Tarsus Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
74

TARS
Tarsus Pharmaceuticals

Last Price:
46.65
Seasonality Move:
21.76%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Tarsus Pharmaceuticals Price Quote

$46.65
+0.15 (+0.32%)
(Updated: November 14, 2024 at 5:15 PM ET)

Tarsus Pharmaceuticals Key Stats

Buy
74
Tarsus Pharmaceuticals (TARS) is a Buy
Day range:
$46.22 - $48.84
52-week range:
$15.60 - $51.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.56
P/B ratio:
7.18%
Volume:
777.9K
Avg. volume:
829.1K
1-year change:
170.82%
Market cap:
$1.8B
Revenue:
$17.4M
EPS:
$-4.48

How Much Does Tarsus Pharmaceuticals Make?

Is Tarsus Pharmaceuticals Growing As A Company?

Data Unavailable

Tarsus Pharmaceuticals Stock Price Performance

What Is Tarsus Pharmaceuticals 52-Week High & Low?

Tarsus Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tarsus Pharmaceuticals?

Is Tarsus Pharmaceuticals Cash Flow Positive?

  • What Is TARS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$123.9M
  • What Is Tarsus Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $275.7M
  • What Is Tarsus Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$77.5M

Tarsus Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    TARS return on invested capital is -59.01%
  • What Is Tarsus Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -51.79%
  • What Is TARS Return On Equity?
    ROE is a measure of profitability and is -69.1%

Tarsus Pharmaceuticals Earnings Date & Stock Price

Tarsus Pharmaceuticals Competitors

Tarsus Pharmaceuticals Dividend Yield

Tarsus Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.8%
Revenue: 0% 27.35%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 59.33
Upside from Last Price: 27.6%

Major Shareholders

  • How many TARS shares are owned by institutional investors?
    66.6M TARS shares are owned by institutional investors
  • How many TARS shares are owned by insiders?
    1.7M TARS shares are owned by insiders